News

Opus Genetics to Showcase Innovations at Major Investor Events

Opus Genetics to Showcase Innovations at Major Investor Events

Opus Genetics Conference Participation Overview

Opus Genetics, Inc. (Nasdaq: IRD), a dynamic clinical-stage biopharmaceutical company, is dedicated to developing innovative gene therapies aimed at restoring vision and preventing blindness in individuals suffering from inherited retinal diseases. The Company has exciting participation lined up at some prominent investor conferences. These gatherings present a fantastic opportunity for stakeholders to gain insights into the groundbreaking work being done in the field of gene therapy for retinal disorders.

Upcoming Conferences Featuring Opus Genetics

The first event on the agenda is the BTIG 5th Annual Ophthalmology Day, where Dr. Ash Jayagopal, the Chief Scientific and Development Officer of Opus Genetics, will take part in a fireside chat. This engaging dialogue is scheduled for a virtual format, allowing attendees to learn from experts in the field regarding advancements in treatments relevant to ophthalmology. The chat will happen on a designated date, at 1:00 p.m. ET.

Following this, George Magrath, M.D., the Chief Executive Officer, is poised to participate in the Piper Sandler 37th Annual Healthcare Conference. This event will take place in New York, where he will share critical insights through another fireside chat on another specified date at 10:00 a.m. ET. This platform will help him convey company revelations to a broader investor audience.

Webcasting Opportunities

For those eager to access real-time insights, a link to both live and archived webcasts of the Piper Sandler conference will be available. Interested parties can find this valuable information through the Investors section on the Opus Genetics website, which serves as a hub for various company updates and events.

Understanding Opus Genetics and Its Mission

At its core, Opus Genetics operates with a clear mission: to develop effective gene therapies that can reverse the dire fates of patients afflicted with inherited retinal diseases (IRDs). The Company is committed to formulating durable and one-time treatments targeting the root genetic issues that lead to serious retinal conditions.

Notably, the Company’s innovative pipeline is populated with seven AAV-based programs. Among these programs, OPGx-LCA5 stands out for targeting mutations responsible for LCA5-related diseases, while OPGx-BEST1 aims to tackle BEST1-related retinal degeneration. In addition to these, Opus Genetics is developing therapies aimed at RHO, RDH12, and MERTK, providing hope for a variety of genetic challenges faced by patients.

Further Developments

In parallel with its gene therapy advancements, Opus Genetics is also pursuing the development of Phentolamine Ophthalmic Solution 0.75%. This approved small-molecule treatment is geared towards addressing pharmacologically induced mydriasis, with potential applications under evaluation for other conditions like presbyopia and low-light visual disturbances that might arise after keratorefractive surgeries.

Connecting with Opus Genetics

Opus Genetics prides itself on being at the forefront of biopharmaceutical development shown in its base in Research Triangle Park, NC. For anyone looking to delve deeper into the Company’s mission and innovative pipeline, the official website provides extensive resources, insights, and updates.

Stakeholders can remain connected through the investor communication channels, ensuring they stay abreast of developments that might impact the Company’s trajectory and success in the biopharmaceutical landscape.

Frequently Asked Questions

What does Opus Genetics specialize in?

Opus Genetics focuses on developing gene therapies specifically targeted at restoring vision and preventing blindness from inherited retinal diseases.

Which conferences will Opus Genetics attend?

Opus Genetics will participate in the BTIG 5th Annual Ophthalmology Day and the Piper Sandler 37th Annual Healthcare Conference.

Who are the key speakers representing Opus Genetics?

Dr. Ash Jayagopal, Chief Scientific and Development Officer, and Dr. George Magrath, Chief Executive Officer, will represent the Company at these events.

How can I watch the conferences?

The webcasting for the Piper Sandler conference can be accessed on the Opus Genetics website, specifically under the Investors section.

Where is Opus Genetics located?

Opus Genetics is based in Research Triangle Park, North Carolina, where it is advancing its innovative biopharmaceutical programs.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Sunrate's Bold Move: New Payment Bond with Netstorming

Updated Category News Views 53

Sunrate Joins Forces with Netstorming When two industry powerhouses shake hands, it's wise to sit up and listen. Sunrate, the global whiz in payment solutions, has linked arms with Netstorming, a tech-savvy pioneer in the travel sector. This ironclad partnership was announced at World Travel Market London 2026. Owners of travel businesses should take note: things are...

Continue Reading
Tellus Offers Seamless Security with Passkey Sign-In

Updated Category News Views 65

Tellus Brings a New Era of Convenience Even the most innovative, forward-thinking companies occasionally have to change step to keep up with the relentless march of technology. That's what Tellus App, Inc., a proptech company from Silicon Valley, is doing with its latest announcement to offer passkey sign-ins for its savings app across iOS, Android, and the web. In...

Continue Reading
Mill Creek's Bold Move into Denver's Cherry Creek

Updated Category News Views 60

Taking a Stroll Down Cherry Creek The move by Mill Creek Residential into Cherry Creek North is a bold one, but they aren't exactly newcomers to this high-end neighborhood. They're planting their flag with the Modera Second Avenue, targeting Denver's upscale renters. With a Walk Score of 89, the location is a sweet spot for deep-pocketed folks who want the boutiques and...

Continue Reading
BAIC FOTON Expands With New Trucks in Africa

Updated Category News Views 123

Innovation in African Mobility Amidst the sparse horizons of Port Elizabeth, South Africa, BAIC FOTON is shifting gears in a big way. They've rolled out a duo of heavy-duty trucks—the GALAXUS R5 and C5—and topped it off with the TUNLAND V PHEV plug-in hybrid pickup. On October 29, the Africa Regional Partner Conference buzzed with talk of 'Driving to Great,' signaling...

Continue Reading
LITE, RRC, SGRY: Are Shareholders Getting Shortchanged?

Updated Category News Views 39

What's Really Going On Here? Here's the skinny: Halper Sadeh LLC, that hard-hitting investor rights law firm, is poking their noses into some potential red flags over at a few companies you might have heard of—Lumentum Holdings (NASDAQ:LITE), Range Resources (NYSE:RRC), and Surgery Partners (NASDAQ:SGRY). They're sniffing around transactions that might leave the regular...

Continue Reading
Fluence Energy Faces Stock Woes Amid Legal Challenges

Updated Category News Views 60

A Wild Ride for Fluence Energy Shareholders Damn, if you blinked, you might've missed the plummet of Fluence Energy, Inc. (NASDAQ:FLNC). This kind of nosedive, a brutal 34.63% drop, is the stuff investors fear most. It's like finding a flat tire on the road to profits. But here we are, dissecting the mess that unfolded between November 2025 and September 2026. The meat on...

Continue Reading
Levvy AI: Transforming Hidden Hours into Advisory Gold

Updated Category News Views 16

Unlocking Hidden Potential: Levvy AI on the Scene Picture this: you're running an accounting shop and drowning in an ocean of endless tasks, manual entries, and those cursed follow-ups. That's probably the daily grind, right? Well, it looks like Levvy has decided to break those shackles. This company, based over there in Brooklyn, is rolling out these fancy Levvy AI...

Continue Reading
Speakeasy Dispensary Brings Medical Cannabis to Maysville

Updated Category News Views 74

New Chapter for Maysville: Speakeasy Opens Doors Normally, you'd think of medical cannabis expansions as dry numbers and policies, but with Speakeasy Dispensary making its mark in Maysville, it's not just about business; it's a service to the community. Nestled into 317 W 2nd St, this is more than a simple retail spot. It's about bringing medical options straight to the...

Continue Reading
BAC Faces Class Action as Compliance Issues Loom

Updated Category News Views 18

The air around Bank of America (NYSE: BAC) has turned a shade darker, and if you've been following the script, this was only a matter of time. With Capitol Hill heavies like Senator Elizabeth Warren banging the drum, the squabble over compliance isn't just noise—it's a full-blown siren wailing in the middle of the trading floor. Enforcement and Reaction: A Boiling Pot...

Continue Reading
Connecting NIH Data: Transforming Scientific Discoveries

Updated Category News Views 53

Rethinking How Research Data Drives Discovery When researchers generate truckloads of data, finding patterns that lead to breakthroughs often becomes a game of hide and seek. It's like having a jumbo puzzle with pieces scattered all over the place. Enter the NIH Common Fund Data Ecosystem—a game changer attempting to glue together these pieces across the research...

Continue Reading

Top 5 Most Recently Viewed Articles

Effeect Earns Recognition as Premier PPC Marketing Agency

Updated Category News Views 149

Introduction to Effeect's Achievement Effeect, a notable digital marketing agency, has proudly earned the title of Top PPC Agency from DesignRush, highlighting its exceptional expertise in Pay-Per-Click advertising. This distinction emphasizes Effeect’s proven ability to foster growth for its clients through carefully crafted advertising strategies. What Sets Effeect...

Continue Reading
Celebrating Andrea Mitchell: A Trailblazer in Journalism

Updated Category News Views 419

Andrea Mitchell to Be Honored with Gracies Icon Award The Alliance for Women in Media (AWM) has announced that Andrea Mitchell, the esteemed Chief Foreign Affairs Correspondent for NBC News, will be recognized with the prestigious Gracies Icon Award. This notable accolade will be presented at the 2024 Gracies Leadership Awards, which is set to occur at a significant lunch...

Continue Reading
Celebrating Educators: Eyemart Express Joins Forces with Jennifer Hudson

Updated Category News Views 209

Eyemart Express Honoring Teachers with Significant Donations The national optical retailer helps educators see a brighter future for students through impactful donations. Bringing Recognition to Deserving Educators Eyemart Express is shining a light on educators by collaborating with The Jennifer Hudson Show. This partnership is a tribute to three exceptional teachers...

Continue Reading
BAE Systems Secures $16 Million DARPA Contract for Surveillance

Updated Category News Views 184

BAE Systems Wins $16 Million DARPA Contract for Oversight Program BAE Systems' FAST Labs organization has recently been awarded a significant phase 2 contract worth $16 million by the U.S. Defense Advanced Research Projects Agency (DARPA) for its Oversight program. This initiative primarily focuses on developing an autonomous system capable of maintaining continuous...

Continue Reading
Unveiling Tencent Games' Grand Strategy for Gamescom 2025

Updated Category News Views 275

Tencent Games' Grand Strategy at Gamescom 2025 Tencent Games, a major player in the global gaming landscape, has confirmed its participation in gamescom 2025, which will take place in Cologne, Germany, from August 20 to 24. This event signifies Tencent's largest showcase to date, featuring a broad array of over a dozen exciting titles from its vast portfolio of owned and...

Continue Reading